CLINICAL_TRIALS
trial_result
· 2018-12-12
Clinical Trial Update: Study of Different Doses of a Novel Treatment for Onychomycosis [Phase 2]
Summary
Phase 2 trial update of a novel treatment for distal subungual onychomycosis exploring different doses has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Distal, Subungual Onychomycosis | Phase 2 | Status: COMPLETED